FDA Drug Application (125319) for ILARIS by NOVARTIS PHARMS

Back to FDA Applications sponsored by NOVARTIS PHARMS

Application Number125319
Product Number001
FormINJECTABLE; SUBCUTANEOUS
Dosage180MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameILARIS
Active IngredientCANAKINUMAB



Back to FDA Applications sponsored by NOVARTIS PHARMS